11.4.2023
More than half a million people are diagnosed each year with esophageal cancer. It is the 8th most common cancer type and places sixth regarding mortality[1]. Several factors influence the treatment decision with this cancer diagnosis, like the stage of the disease, the tumor site, the pathological type, and the…
Articles
23.3.2023
HELSINKI, Finland - March 23, 2023 MVision AI raises 5.4M€ to make same-day cancer treatment the new standard MVision AI is the first cloud-based AI-powered radiotherapy planning solution for treating cancer. MVision uses artificial intelligence to automate cancer treatments with its unique automatic segmentation tool. The next-generation technology speeds up…
Press Releases
20.2.2023
One of the main characteristics of humans, compared to most other living creatures, is the ability of making tools. Progress has been linked to discoveries and the development of new devices. People have always tried to enhance their capabilities, and our days are not different. But how do we perceive…
19.1.2022
Helsinki - 19th of January, 2022 - MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education designed to support contouring skill instructions for radiation oncologists. EduCase is a computer-based training tool developed by RadOnc eLearning Center, LLC., to assist the development…
News, Press Releases
29.9.2021
Helsinki - 29th of September 2021 - MVision AI, the leading service provider of guideline compliant radiotherapy software, announces a new distribution partnership with AQUILAB, the chief provider of revolutionary oncology software solutions throughout France. (more…)
Subscribe to get information, latest news and other interesting offers about MVision AI
